WEB SEARCH


TOP SELECTION

CONTACT US

info_demofinance@mynasdaq.it

DONATION

All profits of this web site are donated to charity 'the arsenal of peace'. VISIT THE WEBSITE

ADS

Complete financial analysis of UNITED THERAPEUTI (UTHR)

Name UNITED THERAPEUTI
Year low 36.55
Year High 69.01
Symbol UTHR
Last trade 42.8243
Percentage change -1.03
Volume 418,043
Media Volume (3m) 721,576
PE Ratio 9.12
EPS 4.745
Market Cap 2299
Media fatt 801
Trend fatt trend fatt graph for UNITED THERAPEUTI
Media net income 264
Trend net income trend net income for UNITED THERAPEUTI
P / E P / E graph for UNITED THERAPEUTI - 15 points 15
EPS EPS graph for UNITED THERAPEUTI - 15 points 15
MARKET CAP / TOTAL REVENUE market  cap  /  total  revenue  graph for UNITED THERAPEUTI - 2 points 2
TOT REV 1 / TOT REV 2 TOT REV 1 / TOT REV 2 graph for UNITED THERAPEUTI - 5 points 5
NET INC 1 / NET INC 2 NET INC 1 / NET INC 2 graph for UNITED THERAPEUTI - 11 points 11
MED NET INC / MED TOT REV MED NET INC / MED TOT REV graph for UNITED THERAPEUTI - 12 points 12
NET INCOME / MARKET CAP NET  INCOME  /  MARKET  CAP graph for UNITED THERAPEUTI - 6 points 6
TOTALREV1/TOTALREV3 totalRev1/totalRev3 graph for UNITED THERAPEUTI - 4 points 4
NET INC1/NET INC3 net inc1/net inc3 graph for UNITED THERAPEUTI - 3 points 3
TOT REV 2/ TOT REV 3 tot rev 2/ tot rev 3 graph for UNITED THERAPEUTI - 3 points 3
NET INC 2 / NET INC 3 net inc 2 / net inc 3 graph for UNITED THERAPEUTI - 0 points 0
. . graph for UNITED THERAPEUTI - 0 points 0
MARKET CAP / NET TANGIBLE ASSETS MARKET CAP / NET TANGIBLE ASSETS graph for UNITED THERAPEUTI - 2 points 2
MARK CAP/TOT STOCK EQ MARK CAP/TOT STOCK EQ graph for UNITED THERAPEUTI - 0 points 0
MARKET CAP / TOT CURRENT ASSETS market cap / tot current assets graph for UNITED THERAPEUTI - 0 points 0
TOT CURR ASSETS / TOT LIAB TOT CURR ASSETS / TOT LIAB graph for UNITED THERAPEUTI - 0 points 0
. . graph for UNITED THERAPEUTI - 0 points 0
SELL HOLD BUY SELL           HOLD          BUY graph for UNITED THERAPEUTI - 0 points 0
SINTESE 78

GRAPHS

max price logarithm graph for UNITED THERAPEUTI based on no conditions max volume linear graph for UNITED THERAPEUTI based on no conditions

News

United Therapeutics' CEO Discusses Q1 2012 Results - Earnings Call Transcript (Apr 27 - reuters) UPDATE 1-United Therapeutics 1st-qtr beats estimates (Apr 26 - reuters) United Therapeutics 1st-quarter beats estimates (Apr 26 - reuters) United Therapeutics Corporation Reports First Quarter 2012 Financial Results (Apr 26 - reuters) United Therapeutics Corporation To Announce First Quarter 2012 Financial Results Before Market Open On Thursday, April 26, 2012 (Apr 19 - reuters) Midcap Biotech Stocks Being Accumulated By The World's Largest Money Managers (Apr 17 - reuters) 5 Picks To Beat Valeant Pharmaceuticals (Mar 20 - reuters) United Therapeutics sues Sandoz over hypertension drug (Mar 15 - reuters) UPDATE 1-United Therapeutics sues Sandoz over hypertension drug (Mar 15 - reuters) Oral Treprostinil New Drug Application Accepted by FDA for Review (Feb 21 - reuters) United Therapeutics' CEO Discusses Q4 2011 Results - Earnings Call Transcript (Feb 14 - reuters) United Therapeutics Corporation Reports 2011 Fourth Quarter and Annual Financial Results (Feb 14 - reuters) United Therapeutics Corporation to Announce Fourth Quarter and Annual 2011 Financial Results Before Market Open on Tuesday, February 14, 2012 (Feb 07 - reuters) United Therapeutics Receives Paragraph IV Notice Letter for Remodulin (Feb 06 - reuters) United Therapeutics: Look To This Biotech Stock For Healthy Growth (Jan 18 - reuters) United Therapeutics Gets Upgrade on Revenue Growth (Jan 12 - reuters) United Therapeutics Passes This Key Test (Dec 30 - reuters) Insider Buys And Sells: Kinder Morgan, Toll Brothers (Dec 27 - reuters) Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union (Dec 27 - reuters) Insider Buys and Sells: Valeant, Apollo (Dec 11 - reuters) United Therapeutics' CEO Discusses Q3 2011 Results - Earnings Call Transcript (Oct 27 - reuters) United Therapeutics Corporation Reports Third Quarter 2011 Financial Results (Oct 27 - reuters) United Therapeutics Corporation to Announce Third Quarter 2011 Financial Results Before Market Open on Thursday, October 27, 2011 (Oct 20 - reuters) United Therapeutics Prices Private Offering of Convertible Senior Notes and Announces Concurrent Exercise of Overallotment Option (Oct 12 - reuters) United Therapeutics Announces Proposed Private Offering of $210 Million of Convertible Senior Notes and Authorization of Stock Repurchase Program (Oct 11 - reuters) United Therapeutics Subsidiary Enters Into Contract With National Institutes of Health for Award of up to $45 Million to Support Glycobiology Antiviral Program (Oct 10 - reuters) United Therapeutics oral lung drug fails trial, shares slide (Oct 07 - reuters) RPT-Ex-Nasdaq exec gets 42 months for insider trading (Oct 07 - reuters) Ex-Nasdaq executive gets 42 months for insider trading (Oct 07 - reuters) Combat Options Trading on United Therapeutics (Oct 05 - reuters) Biotechnology Firm ImmuneWorks Supports Pulmonary Fibrosis Week by Increasing National Recruitment Efforts to Enroll (Sep 19 - reuters) Biotech Clinical Trials Update (Aug 25 - reuters) United Therapeutics Corporation Special Call (Aug 25 - reuters) US SMALL/MIDCAPS-Early stocks' advance fades on growth concern (Aug 24 - reuters) United Therapeutics Shares Got Crushed: What You Need to Know (Aug 24 - reuters) United Therapeutics oral lung drug fails trial, shares slide (Aug 24 - reuters) FREEDOM-C(2) Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Does Not Meet Primary Endpoint (Aug 24 - reuters) Tuesday Options Recap (Aug 24 - reuters) Ex-Nasdaq exec gets 42 months for insider trading (Aug 12 - reuters) Ex-Nasdaq executive gets 42 months for insider trading (Aug 12 - reuters) United Therapeutics' CEO Discusses Q2 2011 Results - Earnings Call Transcript (Jul 28 - reuters) United Therapeutics Corporation Reports Second Quarter 2011 Financial Results (Jul 28 - reuters) United Therapeutics Corporation To Announce Second Quarter 2011 Financial Results Before Market Open on Thursday, July 28, 2011 (Jul 21 - reuters) » More UTHR.O Market Views (Jul 15 - reuters) 8 Oversold Stocks With High Profitability, Interest Coverage Growth (Jul 13 - reuters) Pandora's Debut and JC Penney's Genius Hire (Jun 16 - reuters) United Therapeutics lung drug disappoints, shares slide (Jun 06 - reuters) FREEDOM-M Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Meets Primary Endpoint (Jun 06 - reuters) United Therapeutics: Growth Engine for Cardiovascular Diseases (Jun 02 - reuters) United Therapeutics: Oversold but Fundamentally Sound (Jun 02 - reuters)

ADS

MY PORTFOLIO



GAIN vs LOSS


BEST vs WORST


SELECTION DIY

Market Cap
Last Trade
Gain/Loss
Webtech:
P / E
EPS
market cap / total revenue
TOT REV 1 / TOT REV 2
NET INC 1 / NET INC 2
MED NET INC / MED TOT REV
NET INCOME / MARKET CAP
totalRev1/totalRev3
net inc1/net inc3
tot rev 2/ tot rev 3
net inc 2 / net inc 3
.
MARKET CAP / NET TANGIBLE ASSETS
MARK CAP/TOT STOCK EQ
market cap / tot current assets
TOT CURR ASSETS / TOT LIAB
.
SELL HOLD BUY